Ruifeng Xu

Associate Principal Scientist
Merck & Co., Inc.
2000 Galloping Hill Road
PO Box 539
Kenilworth, NJ
USA 09033-1310

Papers:
2E-2 BEZLOTOXUMAB IS ASSOCIATED WITH A REDUCTION IN CUMULATIVE HOSPITALIZED DAYS: ANALYSIS OF THE HOSPITALIZATION DATA FROM THE MODIFY I AND II CLINICAL TRIALS